Endpoints News· @endpts · X·· 21 天前AI 评分35
AI 导读
据Endpoints的Signal调查,投资者对Makary离任后的FDA态度转暖,但科学家和大型制药公司仍持谨慎态度。https://endpoints.news/after-makarys-fda-exit-biopharma-exhales-signal-survey/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
Investors are warming to the post-Makary FDA, but scientists and Big Pharma remain guarded, per Endpoints’ Signal survey. https://endpoints.news/after-makarys-fda-exit-biopharma-exhales-signal-survey/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com